USPTO issues new guidelines on Alice/Mayo implementation

The US Patent and Trademark Office (USPTO) has published new guidelines on the eligibility of subject matter in patent applications. The guidelines, issued on Friday, January 4, revised the

A New Horizon: Design Patent Practitioner Bar Proposed by USPTO

The United States Patent and Trademark Office has proposed a rule to create a separate design patent practitioner bar. The USPTO is publishing this proposal in the Federal Register on May 16, 2023.

USPTO warns patent lawyers not to pass off AI inventions as human

information, which it said could result in "critical misstatements and omissions." USPTO director Kathi Vidal said in a statement that the guidance was "part of our work shaping AI policy" and "encourages

USPTO announces new group to mitigate threats to the patent system

April 16, 2025 , the U.S. Patent and Trademark Office (USPTO) announced creating a new group to expand the agency's efforts to mitigate threats and protect the integrity of the U.S. patent system.

Another USPTO AI-assisted examination tool ready for prime time

Beginning in September 2022, utility patent examiners at the U.S. Patent and Trademark Office (USPTO) began conducting prior art searches through the Similarity Search tool (SimSearch), an

Anticipation Bounces Back Electronic Return Receipt Patent as Invalid

from a Massachusetts court underscores this tightrope walk, and serves as a warning that claims drafted too loosely—while allowed by the USPTO—can leave the patent at risk for invalidation by

USPTO trying to cut patent pendency, says Andrei Iancu

The US Patent and Trademark Office (USPTO) has outlined targets to reduce the time it takes to process patent applications, Andrei Iancu, director of the USPTO, has said. Addressing a Senate panel

Informative User Guide for the View and Drawing Requirements of Designs

Who Owns CRISPR?

property landscape. On April 15, 2014, the US Patent and Trademark Office (USPTO) awarded the first patent for use the CRISPR/Cas system to edit eukaryotic genomes to Feng Zhang of the Broad Institute

PTAB’s IBM patent ruling reversed by Court of Appeals

each particular system supporting those applications”. US Patent and Trademark Office (USPTO) director Andrei Iancu acted on behalf of several private companies in filing two inter partes reviews that